Craig Burton

Criag Burton is the senior vice president of policy and strategic alliances at the Association for Accessible Medicines. He is also the executive director of the Biosimilars Council. In his current role, Craig is responsible for leading policy development and issues management for AAM, directing the Biosimilars Council, and building relationships with strategic partners in the health care sector, including patient advocacy groups.

Craig served as deputy assistant secretary for legislation in the US Department of Health and Human Services. In this role, he advised the Secretary, senior Department leaders and White House officials on legislative strategy to achieve key priorities. Craig also served in the Senate, where he was health policy advisor to Senate Majority Leader Bill Frist, MD, and as professional staff on the US Senate Committee on Health, Education, Labor and Pensions.

Opinion: The Inflation Reduction Act is a Step Backward for Biosimilar Competition

August 18, 2022

In response to another opinion piece, Craig Burton, from the Association for Accessible Medicines, argued that the Inflation Reduction Act of 2022 could prevent biosimilar competition, and lower drug prices as a result.